Dabin Liu

机构：Harbin Medical University, Nanjing University of Science and Technology, Fourth Affiliated Hospital of Harbin Medical University · ORCID：0000-0002-3811-8317

发表论文 89 篇 · 总被引 2737 次 · h-index 23

代表论文

• A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis (2024 · Cell Metabolism · 被引 63)
• Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma (2024 · Gut · 被引 63)
• Proteogenomic Identification and Analysis of KIF5B as a Prognostic Signature for Hepatocellular Carcinoma (2024 · Current Gene Therapy · 被引 38)
• An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC (2025 · Journal of Hepatology · 被引 20)
• Succinate supplementation alleviates liver cancer by inhibiting the FN1/SQLE axis-mediated cholesterol biosynthesis (2025 · iScience · 被引 10)
• Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer (2024 · Journal of Inflammation Research · 被引 8)